Research SummaryKey Findings

What research findings exist for Selank regarding anxiety and stress-related behaviors?

Anxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models. Another study reports: some symptom improvements occurred earlier with combined treatment, and health-related quality of life and tolerance indicators show research significance.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
i

Currently, 4 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

Comparison of study design and results

Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.

LiteratureStudy subjects and designObservation and discoveryScope of Explanation
2017 · PMID 28280289Rat anxiety behavior model; Selank alone and combined with diazepamAnxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models.Different emotional situations lead to different results; it is not a verification of human efficacy; conditions and combined interventions cannot be ignored.
2015 · PMID 2635639570 patients with anxiety-related disorders; Selank plus phenazepam compared with monotherapy.Some symptom improvements from combination therapy appear earlier; quality of life and tolerance-related indicators indicate research significance.Part of a combination regimen, cannot attribute all benefits to Selank monotherapy; historical study in 2015.
2014 · PMID 2517626160 patients with anxiety/somatic symptom disorder; Selank compared with phenazepam.The study reports Selank has anti-anxiety effects and partial quality of life improvement.Smaller historical comparative studies; cannot replace modern large-scale placebo-controlled validation.
2008 · PMID 1845409662 patients with generalized anxiety or neurasthenia; Selank compared with medazepam.Both groups had similar anti-anxiety effects, and Selank also showed some observations related to anti-fatigue.2008 historical research; specific patients and comparative drugs, not equivalent to common stress-relief effects in healthy people.

References

Animal Study2017 · Historical basic researchREF. 01

How do anxiety behaviors change under stress conditions?

Research Findings

Anxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models.[1] ↗

Study Design

Rat anxiety behavior model; Selank alone and combined with diazepam

Scope & Limitations

Different emotional situations lead to different results; it is not a verification of human efficacy; conditions and combined interventions cannot be ignored.

View the Article Title and Full Citation+

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.

Kasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P, Shadrina M

Behavioural Neurology · Volume/Issue Year 2017
First published 2017-01-01 · PMID 28280289
DOI 10.1155/2017/5091027

Human Study2015 · Historical basic researchREF. 02

What was observed with the combined regimen including Selank?

Research Findings

Some symptom improvements from combination therapy appear earlier; quality of life and tolerance-related indicators indicate research significance.[2] ↗

Study Design

70 patients with anxiety-related disorders; Selank plus phenazepam compared with monotherapy.

Scope & Limitations

Part of a combination regimen, cannot attribute all benefits to Selank monotherapy; historical study in 2015.

View the Article Title and Full Citation+

[Optimization of the treatment of anxiety disorders with selank].

Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, Gushanskaya EV, Chobanu IK, Sokolov OY, Myasoedov NF

Journal of Neurology and Psychiatry named after S.S. Korsakov · Volume/Issue Year 2015
First published on 2015-01-01 · PMID 26356395
DOI 10.17116/jnevro20151156133-40

Human Study2014 · Historical basic researchREF. 03

How should the anxiety studies of Selank compared to other drugs be interpreted?

Research Findings

The study reports Selank has anti-anxiety effects and partial quality of life improvement.[3] ↗

Study Design

60 patients with anxiety/somatic symptom disorder; Selank compared with phenazepam.

Scope & Limitations

Smaller historical comparative studies; cannot replace modern large-scale placebo-controlled validation.

View the Article Title and Full Citation+

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF

Journal of Neurology and Psychiatry named after S.S. Korsakov · Volume/Issue Year 2014
First published on 2014-01-01 · PMID 25176261
DOI not provided in the database

Human Study2008 · Historical basic researchREF. 04

What was observed in studies of early anxiety patients?

Research Findings

Both groups had similar anti-anxiety effects, and Selank also showed some observations related to anti-fatigue.[4] ↗

Study Design

62 patients with generalized anxiety or neurasthenia; Selank compared with medazepam.

Scope & Limitations

2008 historical research; specific patients and comparative drugs, not equivalent to common stress-relief effects in healthy people.

View the Article Title and Full Citation+

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB

Journal of Neurology and Psychiatry named after S.S. Korsakov · Volume/Issue Year 2008
First published 2008-01-01 · PMID 18454096
DOI not provided in the database

Common issues and corresponding evidence

What research findings exist for Selank regarding anxiety and stress-related behaviors?+

Anxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models. Another study reports: some symptom improvements occurred earlier with combined treatment, and health-related quality of life and tolerance indicators show research significance.[1] ↗ [2] ↗

Do human studies of Selank include monotherapy or combination regimens?+

Both have. Some historical studies compared Selank with anti-anxiety drugs, and others added benzodiazepines. Benefits of combination regimens cannot be fully attributed to Selank monotherapy.[3] ↗ [2] ↗

Selank—these conclusions apply to which study populations?+

Rat anxiety behavior model; Selank alone and combined with diazepam; 70 patients with anxiety-related disorders; comparison of Selank plus phenazepam and alone; 60 patients with anxiety/somatoform disorders; comparison of Selank and phenazepam. Different stress scenarios yield different results; not verification of human efficacy; cannot ignore conditions and combined interventions.[1] ↗ [2] ↗ [3] ↗

Selank

Return to catalog specifications and batch file verification entry.

↗